NCT04812509 2023-02-24
Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3 Completed
Clinical Trials
8 trialsNCT02715856 2022-10-13
Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal Metastases
M.D. Anderson Cancer Center
Phase NA Terminated
NCT04550949 2020-09-22
To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT03071744 2019-12-09
Lazanda in Cancer Patients Receiving Palliative Radiation
University of California, San Diego
Phase 2 Terminated
NCT03550508 2018-06-08
JMT103
Shanghai JMT-Bio Inc.
Phase 1 Unknown
NCT01106352 2017-01-04
A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)
Bayer
Phase 1/2 Completed
NCT01417403 2015-02-03
Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases
Virginia Commonwealth University
Phase 1 Terminated
NCT01339780 2014-02-28
Imaging of Prostate and Breast Cancer Bone Metastases Using Magnetic Resonance Imaging and Nuclear Medicine Techniques
Turku University Hospital
Phase NA Completed